Analyst Reco. CareMax, Inc.

Equities

CMAX

US14171W2026

Market Closed - Nasdaq Other stock markets 21:30:00 03/05/2024 BST			5-day change	1st Jan Change
3.31 ^USD	-4.06%		+6.09%	-77.85%

04-01	UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating	MT
03-18	Transcript : CareMax, Inc., Q4 2023 Earnings Call, Mar 18, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating	04-01	MT
UBS Adjusts CareMax Price Target to $7 From $30, Maintains Neutral Rating	02-08	MT
UBS Downgrades CareMax to Neutral From Buy, Adjusts Price Target to $1 From $5	11-17	MT
Piper Sandler Downgrades CareMax to Neutral From Overweight With $2 Price Target	11-10	MT
UBS Adjusts CareMax Price Target to $5 From $6, Maintains Buy Rating	09/05/23	MT
TD Cowen Downgrades CareMax to Market Perform From Outperform, Adjusts Price Target to $4 From $7	17/03/23	MT
UBS Adjusts CareMax's Price Target to $6 From $10, Maintains Buy Rating	06/01/23	MT
UBS Adjusts CareMax Price Target to $10 From $11, Maintains Buy Rating	06/10/22	MT
UBS Adjusts CareMax Price Target to $11 From $12, Maintains Buy Rating	14/09/22	MT
Truist Securities Starts CareMax at Hold With $7.50 Price Target	07/09/22	MT
UBS Adjusts CareMax Price Target to $12 From $13, Maintains Buy Rating	17/05/22	MT
UBS Adjusts CareMax Price Target to $13 From $14, Maintains Buy Rating	17/03/22	MT
UBS Initiates Coverage on CareMax With Buy Rating, $14 Price Target	07/01/22	MT
CAREMAX : Jefferies Starts CareMax at Buy with $15 Price Target	20/10/21	MT
CAREMAX : Piper Sandler Upgrades CareMax to Overweight From Neutral	13/09/21	MT
CAREMAX : Cowen Starts CareMax at Outperform with $14 Price Target	10/09/21	MT
CAREMAX : Piper Sandler Starts CareMax at Neutral With $14 Price Target	01/07/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer